ArticleTheranostics2021

Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.

Si-Jia Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.